Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Vizamyl

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
INTRODUCTION Since the approval of three 18F labeled β-amyloid-targeting PET imaging agents, Amyvid (florbetapir f18, AV-45… Expand
Is this relevant?
2016
2016
In vivo imaging of fibrillar β-amyloid deposits may assist clinical diagnosis of Alzheimer’s disease (AD), aid treatment… Expand
  • table 1
  • table 2
  • table 2
  • table 2
  • figure 1
Is this relevant?
2015
2015
Medicare’s decision to restrict coverage of florbetapir, a diagnostic agent for Alzheimer’s disease, exemplifies an inconsistent… Expand
Is this relevant?
Review
2015
Review
2015
In Alzheimer’s disease (AD), the deposition of β-amyloid (Aβ) is hypothesized to result in a series of secondary… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
2014
2014
The application of microfluidics to the synthesis of Positron Emission Tomography (PET) tracers has been explored for more than a… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2014
2014
2013年10月25日,美国食品药品监督管理局(FDA)批准由GE Healthcare Ltd的分公司Medi—Physics生产的放射性诊断药物[18F]flutemetamol注射液(Vizamyl)在美国上市。 
Is this relevant?
Review
2014
Review
2014
Therapies targeting amyloid-β peptide currently represent approximately 50% of drugs now being developed for Alzheimer’s disease… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2014
Review
2014
Therapies targeting amyloid-β peptide currently represent approximately 50% of drugs now being developed for Alzheimer's disease… Expand
  • figure 1
Is this relevant?
2013
2013
Physicians in the US who want to see how much amyloid-beta protein has accumulated in the brains of their patients with Alzheimer… Expand
Is this relevant?
2013
2013
There has been tremendous excitement regarding biomarkers that provide in vivo information on neurodegenerative diseases. Until… Expand
Is this relevant?